InvestorsHub Logo
Followers 15
Posts 1682
Boards Moderated 0
Alias Born 12/13/2009

Re: runncoach post# 2910

Sunday, 04/17/2022 5:16:28 PM

Sunday, April 17, 2022 5:16:28 PM

Post# of 3699

You mean AD peer reviewed study that showed 2 patients improved?



You conveniently forgot to mention that Blarcasamine has already demonstrated cognitive improvements in a successful Rett's Syndrome Phase III trial (in a difficult adult population) as well as in a Parkinson's Disease Dementia Phase II trial. But we can revisit cognition improvement this fall when the now fully enrolled 509 patient AD Phase 2b/III reports out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SAVA News